Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Whitney Valins is active.

Publication


Featured researches published by Whitney Valins.


Expert Opinion on Pharmacotherapy | 2009

Pharmacotherapy of actinic keratosis

Brian Berman; Sadegh Amini; Whitney Valins; Samantha G. Block

Actinic keratosis (AK) represents the initial intraepidermal manifestation of abnormal keratinocyte proliferation with the potential of progression to squamous cell carcinoma (SCC). When in limited numbers, clinically visible AKs are treated individually with ablative and/or surgical procedures (lesion-directed treatment), while multiple and sublinical AKs are treated with field-directed therapies that use ablative, nonablating and other topically applied treatment modalities. Owing to difficulties in predicting which AK will progress to SCC, the general rule is to treat all AKs. The goals of treatment are to eliminate the AKs, minimizing their risk of progression to invasive SCC, while pursuing good cosmetic outcomes. Prevention is the most important treatment modality for AKs. Avoidance of sun and artificial sources of ultraviolet light, applying sunscreen and self-examination are among the most effective preventive measures. Chemopreventive modalities such as retinoids, 2-(Difluoromethyl)-dl-ornithine (DFMO), perillyl alcohol, T4 endonuclease V, and dl-α-tocopherol are described. Lesion-directed treatment modalities include cryotherapy, surgery and electrodessication with or without curettage. Field-directed treatment modalities include nonablative and ablative laser resurfacing, dermabrasion, chemical peels, topical immunomodulators (imiquimod, 5-fluorouracil and diclofenac) and photodynamic therapy. And, finally, newer and investigational treatment modalities such as ingenol mebutate, resiquimod and betulinic acid are also being discussed.


Journal of The American Academy of Dermatology | 2011

Exacerbation of facial acne vulgaris after consuming pure chocolate

Samantha G. Block; Whitney Valins; Caroline V. Caperton; Martha H. Viera; Sadegh Amini; Brian Berman

REFERENCES 1. Mueller TJ, Wu H, Greenberg RE, Hudes G, Topham N, Lessin SR, et al. Cutaneous metastases from genitourinary malignancies. Urology 2004;63:1021-6. 2. Miyamoto T, Ikehara A, Araki M, Akaeda T, Mihara M. Cutaneous metastatic carcinoma of the penis: suspected metastasis implantation from a bladder tumor. J Urol 2000;163:1519. 3. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995;3:99-107. 4. Amin MB. Histologic variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications.Mod Pathol 2009;22:S96. 5. Swick B, Gordon J. Superficially invasive transitional cell carcinoma of the bladder associated with distant cutaneous metastases. J Cutan Pathol (Epub ahead of print). 6. HoW, Lee L, Chen C, Tsengand J, Tsai T. An interesting and unique pattern of two distinct coexisting cutaneous metastases of a transitional cell carcinoma. Clin Exp Dermatol 2009;34:e336-8.


Facial Plastic Surgery Clinics of North America | 2011

Laser therapy in black skin.

Heather Woolery-Lloyd; Martha H. Viera; Whitney Valins

This article provides a systematic overview of laser, light, and other energy devices for patients of African descent. It also reviews complications in skin of color and some treatment options for these adverse events.


Archives of Dermatology | 2011

Alteration in Hair Texture Following Regrowth in Alopecia Areata: A Case Report

Whitney Valins; Janelle Vega; Sadegh Amini; Heather Woolery-Lloyd; Lawrence A. Schachner

BACKGROUND Alopecia areata is a common cause of hair loss seen in 3.8% of patients in dermatology clinics and in 0.2% to 2.0% of the general US population. The pathology of the disease remains poorly understood. Hair loss in alopecia areata can range from a single patch to 100% loss of body hair. When hair regrowth occurs in alopecia areata, the new hair may demonstrate pigment alterations, but a change in hair texture (ie, curly or straight) has rarely been reported as a consequence of alopecia areata. OBSERVATIONS We report a case of a 13-year-old African American boy who experienced an alteration of hair shape following regrowth after alopecia areata. The new hair recapitulated his hair shape from early childhood. CONCLUSIONS The precipitating factor for a change in hair texture in alopecia areata may be a result of treatment, pathophysiologic changes, or a combination of both. Whether the change is triggered at the level of stem cell differentiation, by cytokine or hormonal influences, gene expression during hair follicle development, a combination of all of these, or an unknown cause is a question that remains to be answered.


Dermatologic Surgery | 2011

Letter: A Comparison Study of the Tensile Strength of Sutures Used in Dermatologic Surgery Following Exposure to Petrolatum

Vidya S. Rajpara; Whitney Valins; Martha H. Viera; Sadegh Amini; Sailesh Konda; Panta Rouhani; Brian Berman

A variety of sutures are currently used in dermatologic surgery, each with unique characteristics that include suture material, number of filaments, diameter, fluid absorption ability, elasticity, memory and plasticity, ability of the suture to cut through tissue, and tensile strength (TS). These characteristics, along with nature of the wound, such as its location, shape, and size, and the preference and previous experience of the surgeon, help to determine the type of suture to be used in each individual case.


Clinical Medicine Reviews in Oncology | 2011

Pharmacotherapy of Basal Cell Carcinoma, Anogenital Warts, and Actinic Keratoses: Focus on Topical Imiquimod

Caroline V. Caperton; Martha H. Viera; Sadegh Amini; Whitney Valins; Brian Berman

Imiquimod, an imidazoquinoline compound, has been widely-recognized for its ability to induce both innate and adaptive immune responses. Topical imiquimod has been approved for the treatment of actinic keratoses (AK), external genital warts (EGW), and superficial basal cell carcinoma (BCC). There are reports of many successful off-label uses as well. The pharmacology and mechanisms of action, safety, efficacy, and adverse effects with regards to differing concentrations and dosing regimens are discussed in depth in this chapter. Field-directed therapies for AK along with non-surgical treatments for BCC are rapidly-evolving, with increasing numbers of studies providing evidence-based rationale for their use in management.


Archives of Dermatology | 2010

Asymptomatic Tumors in a 64-Year-Old Man—Quiz Case

Whitney Valins; Robb Marchione; Cheryl Aber; Sadegh Amini; Naomi Montague; Clara Milikowski; Brian Berman

Cary Chisholm, MD; Brook Brouha, MD, PhD; Phillip Lee, MD; Doyle Hansen, MD; Clay Cockerell, MD; Scott & White Memorial Hospital, Temple, Texas (Dr Chisholm); Texas A&M University Health Sciences Center, College Station (Dr Chisholm); University of California, San Diego (Drs Brouha, Lee, and Hansen); University of Texas Southwestern Medical Center, Dallas (Drs Brouha and Cockerell); and Dermpath Diagnostics, Dallas (Drs Brouha and Cockerell)


The Journal of clinical and aesthetic dermatology | 2010

Innovative therapies in the treatment of keloids and hypertrophic scars.

Martha H. Viera; Sadegh Amini; Whitney Valins; Brian Berman


The Journal of clinical and aesthetic dermatology | 2010

Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Sadegh Amini; Martha H. Viera; Whitney Valins; Brian Berman


The Journal of clinical and aesthetic dermatology | 2010

The Expression of Toll-like Receptors in Dermatological Diseases and the Therapeutic Effect of Current and Newer Topical Toll-like Receptor Modulators

Whitney Valins; Sadegh Amini; Brian Berman

Collaboration


Dive into the Whitney Valins's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge